Purchase Order 75N94020P00446
- Not listed
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency under the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of scientific instruments, reagents, and services. The contract, valued at $119,502.00, is for a service agreement to provide the LavisionUltra Microscope II. The contract has no set-aside designation and is intended to support the NIA's research activities, with...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of scientific instruments and reagents. The $24,857.50 contract is for the provision of a DISSOCIATOR INSTRUMENT WITH HEATING UNITS, with a period of performance ending on October 30, 2022. This award is not associated with a larger contract...
- This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of goods. The $211,830 contract is for the provision of Miltenyi's biotechnology products and services to support biomedical research and cell and gene therapy, including instruments, reagents, kits, and antibodies. The award does not have a set-aside...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The $4,250.00 contract does not have a set-aside designation. The contract provides for the delivery and installation of Miltenyi...
- This is a $23,230 firm fixed-price purchase order contract awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute on Aging, a civilian federal agency. The contract delivers specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation, including flow cytometers, cell sorters, tissue dissociators, automated cell separation systems, and associated consumables. Miltenyi Biotec has an...
- This is a $18,639.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is for the delivery of Miltenyi's tissue dissociator and associated laboratory equipment. This award is part of a larger indefinite delivery contract (IDC) worth $2.3 million that Miltenyi Biotec holds with the NIH Clinical...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of a cell dissociator and cell separator. The award, valued at $58,517.50, was made without a set-aside designation and has an ultimate completion date of September 30, 2017. Miltenyi Biotec is a well-established federal contractor,...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Miltenyi Biotec, Inc. in the amount of $24,646.00. The contract is for the delivery of Miltenyi's GentleMACS instruments and associated products, which are used for cell separation, analysis, and processing in biomedical research. Miltenyi Biotec is a global biotechnology company that provides specialized scientific equipment, reagents, and...
- This firm fixed-price purchase order in the amount of $81,701.96 was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. for a preventative maintenance and service agreement for a LaVision light sheet microscope. The award was made on a non-competitive basis pursuant to simplified acquisition procedures without a set-aside. Miltenyi Biotec is a global biotechnology company that provides specialized scientific...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc. for the full service of a Lavision UltraMicroscope II (lasers excluded). The contract, valued at $15,530.00, has a period of performance from August 1, 2020 to July 31, 2021 and does not have a set-aside designation. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The company has extensive experience as a prime contractor for federal agencies, including the NIH, VA, FDA, DoD, CDC, and USDA, supplying a range of products and services related to cell separation, analysis, and processing technologies. In addition to this purchase order, Miltenyi Biotec holds a $2.3 million indefinite delivery contract (IDC) with the NIH Clinical Center, awarded in June 2023, to provide proprietary CliniMACS cell isolation reagents and consumables in support of the center's cell processing and manufacturing capabilities for investigational cell therapy products used in clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 6/22/20 |